Mammography

The Diagnostic Imaging mammography modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of mammography, including 2D digital mammography, digital breast tomosynthesis, and breast ultrasound.

Study Finds No Difference Between Digital Breast Tomosynthesis and Digital Mammography in Cancer Detection for BI-RADS 4 Lesions

May 25, 2022

In a study of over 11,500 patients who had BI-RADS 4 breast lesions with no prior history of breast cancer, researchers found no statistically significant differences between digital mammography and digital breast tomosynthesis in cancer detection rates or biopsy-derived positive predictive value.

Is Digital Breast Tomosynthesis Superior to Digital Mammography?

May 23, 2022

A closer look at the literature suggests the combination of digital breast tomosynthesis (DBT) and two-dimensional (2D) digital mammography (DM) has relatively equivalent cancer detection rates as using DM alone, according to a recent presentation at the Society of Breast Imaging (SBI)/American College of Radiology (ACR) conference.

What is Your Radiology Delta?

May 23, 2022

Amid a glut of unnecessary imaging requests, common worklist frustrations and perceptions from other clinicians that they can interpret medical images just as well, recognizing your role as a humble difference maker may provide the ultimate RVU for patients.

Diagnostic Imaging's Weekly Scan: May 15-May 21

May 21, 2022

Catch up on the top radiology content of the past week.

New Study Points to Longer Duration of Axillary Lymphadenopathy After COVID-19 Vaccine

May 20, 2022

While COVID-19 vaccine clinical trials noted that post-vaccine axillary lymphadenopathy lasted for one to 10 days, emerging breast ultrasound research found a mean resolution of 127 days after a first vaccine dose.

Large Study Finds Elevated 10-Year Breast Cancer Risks in Women with Dense Breasts and Benign Breast Disease

May 18, 2022

Researchers found that Korean women with a combination of benign breast disease and BI-RADS category C or BI-RADS category D breast density had a nearly threefold or greater 10-year risk for breast cancer.

RadNet Gets FDA Nods for AI-Powered Mammography and Prostate MRI Software Algorithms

May 17, 2022

Could the emerging artificial intelligence platforms Saige-Dx and Quantib Prostate 2.0 improve cancer detection with mammography and prostate MRI?

Volpara to Highlight Recent Additions to Breast Cancer Assessment Software at SBI/ACR Conference

May 16, 2022

The company will spotlight the breast cancer risk stratification software Volpara Risk Pathways and a new mammography training collaboration with Mammography Educators.

Diagnostic Imaging's Weekly Scan: April 24-April 30

April 30, 2022

Review the top radiology content from the past week.

Can AI-Powered Mammography Screening be a Game Changer?

April 25, 2022

In a retrospective study involving mammography screening in over 114,000 women, researchers found that an artificial intelligence model had comparable specificity and sensitivity to radiologist screenings, reduced false positive results by 25 percent and reduced radiologist workload by more than 62 percent.